Clinical Trials - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509244242

Publication Date:

September 20, 2024

Pages:

111

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial 鈥� their approval does not mean that the therapy is 'safe' or effective, only that the trial may be conducted.
The global market for Clinical Trials was estimated to be worth US$ 46670 million in 2023 and is forecast to a readjusted size of US$ 62370 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030
The industry's leading producers are Parexel, PRA Health and LabCorp (Covance), which accounted for 4.94%, 7.25% and 11.81% of revenue in 2019, respectively. By region, North America has the highest share of income, at more than 39 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trials, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trials by region & country, by Type, and by Application.
The Clinical Trials market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trials.
麻豆原创 Segmentation
By Company
IQVIA
Charles River Laboratory
ICON Plc
Labcorp Drug Development
Parexel
PPD, Inc. (Thermo Fisher)
Syneos Health
Wuxi AppTec Inc.
Tigermed Consulting
Boji Medical
Medpace Holdings, Inc.
Segment by Type:
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Small Molecules
Biologics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Clinical Trials manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Clinical Trials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Clinical Trials in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Clinical Trials Product Introduction
1.2 Global Clinical Trials 麻豆原创 Size Forecast
1.3 Clinical Trials 麻豆原创 Trends & Drivers
1.3.1 Clinical Trials Industry Trends
1.3.2 Clinical Trials 麻豆原创 Drivers & Opportunity
1.3.3 Clinical Trials 麻豆原创 Challenges
1.3.4 Clinical Trials 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Clinical Trials Players Revenue Ranking (2023)
2.2 Global Clinical Trials Revenue by Company (2019-2024)
2.3 Key Companies Clinical Trials Manufacturing Base Distribution and Headquarters
2.4 Key Companies Clinical Trials Product Offered
2.5 Key Companies Time to Begin Mass Production of Clinical Trials
2.6 Clinical Trials 麻豆原创 Competitive Analysis
2.6.1 Clinical Trials 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Clinical Trials Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trials as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Phase I
3.1.2 Phase II
3.1.3 Phase III
3.1.4 Phase IV
3.2 Global Clinical Trials Sales Value by Type
3.2.1 Global Clinical Trials Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Clinical Trials Sales Value, by Type (2019-2030)
3.2.3 Global Clinical Trials Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Small Molecules
4.1.2 Biologics
4.2 Global Clinical Trials Sales Value by Application
4.2.1 Global Clinical Trials Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Clinical Trials Sales Value, by Application (2019-2030)
4.2.3 Global Clinical Trials Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Clinical Trials Sales Value by Region
5.1.1 Global Clinical Trials Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Clinical Trials Sales Value by Region (2019-2024)
5.1.3 Global Clinical Trials Sales Value by Region (2025-2030)
5.1.4 Global Clinical Trials Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Clinical Trials Sales Value, 2019-2030
5.2.2 North America Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Clinical Trials Sales Value, 2019-2030
5.3.2 Europe Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Clinical Trials Sales Value, 2019-2030
5.4.2 Asia Pacific Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Clinical Trials Sales Value, 2019-2030
5.5.2 South America Clinical Trials Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Clinical Trials Sales Value, 2019-2030
5.6.2 Middle East & Africa Clinical Trials Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Clinical Trials Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Clinical Trials Sales Value
6.3 United States
6.3.1 United States Clinical Trials Sales Value, 2019-2030
6.3.2 United States Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Clinical Trials Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Clinical Trials Sales Value, 2019-2030
6.4.2 Europe Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Clinical Trials Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Clinical Trials Sales Value, 2019-2030
6.5.2 China Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.5.3 China Clinical Trials Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Clinical Trials Sales Value, 2019-2030
6.6.2 Japan Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Clinical Trials Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Clinical Trials Sales Value, 2019-2030
6.7.2 South Korea Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Clinical Trials Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Clinical Trials Sales Value, 2019-2030
6.8.2 Southeast Asia Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Clinical Trials Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Clinical Trials Sales Value, 2019-2030
6.9.2 India Clinical Trials Sales Value by Type (%), 2023 VS 2030
6.9.3 India Clinical Trials Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IQVIA
7.1.1 IQVIA Profile
7.1.2 IQVIA Main Business
7.1.3 IQVIA Clinical Trials Products, Services and Solutions
7.1.4 IQVIA Clinical Trials Revenue (US$ Million) & (2019-2024)
7.1.5 IQVIA Recent Developments
7.2 Charles River Laboratory
7.2.1 Charles River Laboratory Profile
7.2.2 Charles River Laboratory Main Business
7.2.3 Charles River Laboratory Clinical Trials Products, Services and Solutions
7.2.4 Charles River Laboratory Clinical Trials Revenue (US$ Million) & (2019-2024)
7.2.5 Charles River Laboratory Recent Developments
7.3 ICON Plc
7.3.1 ICON Plc Profile
7.3.2 ICON Plc Main Business
7.3.3 ICON Plc Clinical Trials Products, Services and Solutions
7.3.4 ICON Plc Clinical Trials Revenue (US$ Million) & (2019-2024)
7.3.5 Labcorp Drug Development Recent Developments
7.4 Labcorp Drug Development
7.4.1 Labcorp Drug Development Profile
7.4.2 Labcorp Drug Development Main Business
7.4.3 Labcorp Drug Development Clinical Trials Products, Services and Solutions
7.4.4 Labcorp Drug Development Clinical Trials Revenue (US$ Million) & (2019-2024)
7.4.5 Labcorp Drug Development Recent Developments
7.5 Parexel
7.5.1 Parexel Profile
7.5.2 Parexel Main Business
7.5.3 Parexel Clinical Trials Products, Services and Solutions
7.5.4 Parexel Clinical Trials Revenue (US$ Million) & (2019-2024)
7.5.5 Parexel Recent Developments
7.6 PPD, Inc. (Thermo Fisher)
7.6.1 PPD, Inc. (Thermo Fisher) Profile
7.6.2 PPD, Inc. (Thermo Fisher) Main Business
7.6.3 PPD, Inc. (Thermo Fisher) Clinical Trials Products, Services and Solutions
7.6.4 PPD, Inc. (Thermo Fisher) Clinical Trials Revenue (US$ Million) & (2019-2024)
7.6.5 PPD, Inc. (Thermo Fisher) Recent Developments
7.7 Syneos Health
7.7.1 Syneos Health Profile
7.7.2 Syneos Health Main Business
7.7.3 Syneos Health Clinical Trials Products, Services and Solutions
7.7.4 Syneos Health Clinical Trials Revenue (US$ Million) & (2019-2024)
7.7.5 Syneos Health Recent Developments
7.8 Wuxi AppTec Inc.
7.8.1 Wuxi AppTec Inc. Profile
7.8.2 Wuxi AppTec Inc. Main Business
7.8.3 Wuxi AppTec Inc. Clinical Trials Products, Services and Solutions
7.8.4 Wuxi AppTec Inc. Clinical Trials Revenue (US$ Million) & (2019-2024)
7.8.5 Wuxi AppTec Inc. Recent Developments
7.9 Tigermed Consulting
7.9.1 Tigermed Consulting Profile
7.9.2 Tigermed Consulting Main Business
7.9.3 Tigermed Consulting Clinical Trials Products, Services and Solutions
7.9.4 Tigermed Consulting Clinical Trials Revenue (US$ Million) & (2019-2024)
7.9.5 Tigermed Consulting Recent Developments
7.10 Boji Medical
7.10.1 Boji Medical Profile
7.10.2 Boji Medical Main Business
7.10.3 Boji Medical Clinical Trials Products, Services and Solutions
7.10.4 Boji Medical Clinical Trials Revenue (US$ Million) & (2019-2024)
7.10.5 Boji Medical Recent Developments
7.11 Medpace Holdings, Inc.
7.11.1 Medpace Holdings, Inc. Profile
7.11.2 Medpace Holdings, Inc. Main Business
7.11.3 Medpace Holdings, Inc. Clinical Trials Products, Services and Solutions
7.11.4 Medpace Holdings, Inc. Clinical Trials Revenue (US$ Million) & (2019-2024)
7.11.5 Medpace Holdings, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Clinical Trials Industrial Chain
8.2 Clinical Trials Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Clinical Trials Sales Model
8.5.2 Sales Channel
8.5.3 Clinical Trials Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

IQVIA
Charles River Laboratory
ICON Plc
Labcorp Drug Development
Parexel
PPD, Inc. (Thermo Fisher)
Syneos Health
Wuxi AppTec Inc.
Tigermed Consulting
Boji Medical
Medpace Holdings, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.